Latest Articles

Publication Date
Endometriosis - on the intersection of modern environmental pollutants and ancient genetic regulatory variants.

Endometriosis is a chronic, estrogen-driven inflammatory disorder affecting approximately 10% of reproductive-aged women globally. Despite increasing genomic insights into advanced-stage disease, the genetic underpinnings of early-stage endometriosis remain poorly understood, …

Published: Nov. 20, 2025, midnight
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International

Published: Nov. 14, 2025, 4:25 a.m.
Proteomics $2.2M R&D rebate to fuel diagnostics test rollout - The Sydney Morning Herald

Proteomics $2.2M R&D rebate to fuel diagnostics test rollout The Sydney Morning Herald

Published: Nov. 12, 2025, 5:39 a.m.
Proteomics International secures WA Government grant to advance world-first blood test for endometriosis - BiotechDispatch

Proteomics International secures WA Government grant to advance world-first blood test for endometriosis BiotechDispatch

Published: Nov. 9, 2025, midnight
Proteomics International Secures Grant for Endometriosis Diagnostic Test - TipRanks

Proteomics International Secures Grant for Endometriosis Diagnostic Test TipRanks

Published: Nov. 6, 2025, 8:43 a.m.
Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test - MarketScreener

Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test MarketScreener

Published: Nov. 6, 2025, 6:30 a.m.
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant - ABN Newswire

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant ABN Newswire

Published: Nov. 6, 2025, 3:51 a.m.
Metabolome analysis as a potential source of endometriosis biomarkers with the use of multiomics approach in its diagnosis - Nature

Metabolome analysis as a potential source of endometriosis biomarkers with the use of multiomics approach in its diagnosis Nature

Published: Nov. 5, 2025, 1:30 p.m.
Metabolome analysis as a potential source of endometriosis biomarkers with the use of multiomics approach in its diagnosis.

Endometriosis poses diagnostic challenges. This study aimed to analyze the metabolomic profiles of plasma and peritoneal fluid samples obtained from women with endometriosis compared to controls. Our multicenter study involved …

Published: Nov. 5, 2025, midnight
Nanodrug impact on female reproductive health and fetal development: From translation approaches to long-term safety concern.

Biomaterials for drug delivery offer significant advantages over conventional medications, including enhanced cellular uptake, improved drug stability, targeted delivery, and controlled drug release. Cutting-edge nanodrugs delivery approaches such as drugs …

Published: Nov. 5, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!